0% found this document useful (0 votes)
20 views29 pages

Sickle Cell Anemia

Sickle cell disease is a genetic disorder characterized by abnormal hemoglobin, leading to sickle-shaped red blood cells and various complications such as vaso-occlusive crises and stroke. It is most prevalent in Sub-Saharan Africa and has significant childhood mortality rates. Management includes avoiding triggers, vaccinations, and treatments like hydroxyurea and gene therapy.

Uploaded by

dionismachange
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
20 views29 pages

Sickle Cell Anemia

Sickle cell disease is a genetic disorder characterized by abnormal hemoglobin, leading to sickle-shaped red blood cells and various complications such as vaso-occlusive crises and stroke. It is most prevalent in Sub-Saharan Africa and has significant childhood mortality rates. Management includes avoiding triggers, vaccinations, and treatments like hydroxyurea and gene therapy.

Uploaded by

dionismachange
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 29

SICKLE CELL ANEMIA

DR.JAMILA SHEMWETA
DEFINITION

• Sickle cell disease is a genetic disorder that


affects red blood cells causing them to
become sickled or crescent shaped.

• The effects of this condition is due to the


abnormality of the hemoglobin molecules
found in red blood cells
HEMOGLOBIN

• The oxygen carrying pigment and predominant


protein in the red blood cells

• Hb forms an unstable reversible bond with


oxygen

• Oxyhemoglobin: oxygenated

• Deoxyhemoglobin : reduced
HEMOGLOBIN

• Each Hb molecule is made up of four heme


groups surrounding a globin group
• Heme contains iron and gives red color to the
molecule
• Globin consists of two linked pairs of
polypeptide chains
GENETICS OF SCD

• SCD is Hb disorders results from the inheritance of


sickle β-globin gene

• Substitution of valine for glutamic acid aa in the


position 6 of β globin chain (GAG→GTG)

• The homozygous state(HbSS or sickle cell anaemia) is


the most common form of SCD
GENETICS OF SCD
INHERITANCE:
EPIDEMIOLOGY
• High Prevalence: Sub-Saharan Africa, The
Mediterranean basin, The Middle East & India.

• Highest burden: In Africa


• 75% of the 300,000 global births of SCD per year
• Childhood mortality remains high (50 and 90%)

• Tanzania: Amongst top 5 countries in the world with


the highest estimated No. of new-borns (11,000/yr)
• Most affected regions: Eastern coast and North west
Region around lake Victoria.
PATHOPHYSIOLOGY OF SCA
PATHOPHYSIOLOGY OF SCA..

12
1. VASO-OCCLUSIVE CRISES: PAINFUL CRISIS

• Most frequent.

• Triggers: Infection, acidosis,


dehydration or deoxygenation

• Infarcts causing severe pain


occur in the bones

• Hips, Shoulders and


Vertebrae are commonly
affected
1. VASO-OCCLUSIVE CRISES: VISCERAL CRISIS

• Infarction and pooling of blood, often with a severe


exacerbation of anaemia.

A. The acute sickle chest syndrome

• New pulmonary infiltrate, presenting with chest pain,


dyspnoea,↓SO2

• Most common cause of death both in children and adults.


1. VASO-OCCLUSIVE CRISES: VISCERAL CRISIS..
B. Hepatic Sequestration
• Hepatic sequestration
• Intrahepatic cholestasis
• Transfusion-acquired infection
• Transfusional haemosiderosis.

C. Splenic sequestration
• Typically seen in infants
• Presents with splenomegaly, ↓Hb and abdominal
pain.
1. VASO-OCCLUSIVE CRISES: VISCERAL CRISIS..
D. Autosplenectomy

• Splenomegaly occurs in infancy and early childhood but


later often ↓size as a result of infarcts.

• Continued splenic dysfunction eventually leads to


infarction and loss of splenic function
• Predisposing to infection by encapsulated organisms
2. APLASTIC CRISIS
• Occur as a result of infection with parvovirus or from FA
deficiency
• Characterized by a sudden ↓Hb and reticulocytes,
• usually requiring transfusion.

Stroke- one of the leading cause of death.


-can be ischemic, haemorrhagic stroke,
TIA, cerebral venous thrombosis.
3. STROKE
• One of the leading cause of death.

• Can be:
• Ischemic stroke
• Haemorrhagic stroke
• TIA
• cerebral venous thrombosis.
4. HAEMOLYTIC CRISIS
• Increase hemolysis→ ↓ Hb, ↑ Retics count

• Usually accompanied by painful crisis

• Sickle RBCs are mechanically weak and are prone to


intravascular haemolysis
• However the leading mechanism is extravascular hemolysis
by RES

• The life time of sickle RBCs ranges 10-20 days


DIAGNOSIS OF SCA
• Hx and Physical examination
• Sx of anaemia, pain, difficult in breathing
• O/E: Pale, Jaundice, boozing of the skull,LL
oedema

• Systemic examination:
• CNS, CVS, RS, PA, GU, MSS
LAB INVESTIGATIONS
Screening tests
• Sickling test
• Solubility test

• PBS
• Sickle cells and target cells
CONFIRMATORY TESTS
• Hb electrophoresis
• Isoelectric focusing
• HPLC to determine percentages of HbS, HbF
and HbA

Genetic studies: PCR


OTHER INVESTIGATIONS:
• CBC, Retics count
• Chest x-ray, blood gas
• Liver enzymes, abdominal ultrasound.
• LDH, Creatinine and urea
• Consider X-ray of extremities
• Head CT if neurological changes
• Newborn screen
MANAGEMENT:
• Avoid precipitants

• Folic acid

• Good general nutrition and hygiene.

• Vaccination :Pneumococcal, Haemophilus and meningococcal


vaccination

• Hepatitis B vaccination is also given as transfusions may be needed.

• Crises: Rest, warmth, Rehydration by oral fluids and/or intravenous


normal saline, analgesics
MANAGEMENT..
• Gene therapy

• HSCT

• Hydroxyurea
• Reactivates Fetal Hb production
• ↓severity of attacks
• ↑life span

• Chronic Transfusion Therapy


TRANSFUSION IN SCA
• Transfusion ↑ the risk of Fe overload and
allo-immunization

• Indicated when there is evidence benefit of


reduced morbidity and mortality
• Stroke, ACS, Severe painful crises, Symptomatic
anemia, Perioperative
SICKLE CELL TRAIT (HBAS)
• Benign condition that has no haematological
manifestations

• Associated with Normal growth and life expectancy.

• The ratio of HbA to HbS is 60:40, owing to the greater


affinity of α-globin chains for βA-globin chains.

• Sickling and vaso-occlusion under extreme


circumstances can lead to Rhabdomyolysis, Acute Renal
Failure and Cardiac arrhythmias
THANK YOU

You might also like